Neuren Pharmaceuticals (NK9.STU) Q3 2026 Earnings

24AugConfirmed
Q1 2026
Q3 2026
0.01
0.03
0.05
0.07

Details

Expected EPS
0.052804852793913
Actual EPS
0.0225907552629
Surprise EPS
-0.03
Surprise Percent
+57.22%

Description

Neuren Pharmaceuticals (NK9.STU) has reported earnings of 0.0225907552629 per share for Q3 2026.

0 Comments

Share your thoughts